A landmark research initiative analysing blood proteins could catalyse significant advancements in disease treatment and prevention, presenting substantial opportunities for healthcare sector investors. The extensive UK-based study, backed by 14
Healthcare9- Page
177Articles
British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with
The National Health Service faces unprecedented pressure as nine hospitals across England declare critical incidents, with patients experiencing wait times of up to two days in Accident and Emergency departments.
Novo Nordisk, the Danish pharmaceutical powerhouse, has invested hundreds of thousands of pounds in sponsorship deals with major UK pharmacy chains, including Boots and Lloyds, to enhance sales of its
The UK pharmacy sector witnessed a significant wave of consolidation as nearly one in ten pharmacies were acquired through mergers and acquisitions in the 12 months to June 2024, amid
Britain’s children are facing an unprecedented health crisis as poor nutrition and rising obesity rates continue to plague the nation’s youth. Recent NHS data reveals a stark reality: one in
British pharmaceutical giant AstraZeneca has distributed approximately £45 million to Russian healthcare professionals and organisations since the outbreak of the Ukraine war, despite mounting UK military support for Kyiv. The
The aggressive marketing of weight-loss injections to British consumers has sparked significant concern amongst healthcare experts, who are witnessing what they describe as a “wild west” approach to pharmaceutical promotion.
Critical concerns are emerging regarding the National Health Service’s operational effectiveness as it awaits Wes Streeting’s comprehensive 10-year reform plan. The Institute for Public Policy Research (IPPR) has raised significant
A groundbreaking personalised cancer treatment is emerging from an unexpected location: Stevenage High Street. UK biotech firm Autolus has received FDA approval to manufacture and distribute its innovative Car-T cell
Danish pharmaceutical giant Novo Nordisk witnessed a staggering $100 billion erosion in market value following disappointing results from its latest obesity drug trial. The company’s shares experienced their most significant
The United Kingdom’s weight-loss medication market has witnessed an unprecedented surge, with more than 500,000 individuals now utilising revolutionary anti-obesity drugs Mounjaro and Wegovy. This dramatic increase has occurred within
In a significant development for the UK healthcare sector, the NHS has announced the introduction of a groundbreaking once-daily tablet for advanced breast cancer treatment. This strategic move is projected
In a significant move strengthening its technological capabilities, AstraZeneca has appointed Arm Holdings Chief Executive Rene Haas to its board as a non-executive director, effective from next month. The appointment
In a significant development for medical research, UK scientists are pioneering a revolutionary approach to treating rare genetic diseases through a £50 million initiative backed by the Medical Research Council.
Groundbreaking research indicates that popular weight-loss medications like Ozempic, Wegovy, and Mounjaro might have far-reaching applications beyond obesity treatment, potentially revolutionising the approach to various chronic conditions. Dr Mo Sarhan,
